Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Gapping uo/down: PCLN +4%, DPZ +3%, and HTZ +2% after earnings, SBY +18% after M&A news, X +3% after upgrade; TGT -13%, WDAY -5%, VRX -4% and AZO -1% after earnings<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>:</p><ul><li><strong>NTRI</strong> +19.4%, <strong>PAH</strong> +5.6%, <strong>KND</strong> +5.1%, <strong>BWXT</strong> +5%, <strong>FRO</strong> +4.8%, <strong>USCR</strong> +4.7%, <strong>IONS</strong> +4.5%, <strong>GOGL</strong> +4.4%, <strong>TCMD</strong> +4.3%</li><li><strong>PCLN</strong> +4.2%, <strong>NRG</strong> +4.2%, <strong>AMRN</strong> +4.1%, <strong>ICD</strong> +3.7%, <strong>ANTH</strong> +3%, <strong>ESV</strong> +2.8%, <strong>DPZ</strong> +2.7%, <strong>HTZ</strong> +2%, <strong>WUBA</strong> +2%, <strong>HSKA</strong> +1.9%</li><li><strong>NLNK</strong> +1.9%, <strong>EOG</strong> +1.6%, <strong>ALB</strong> +1.5%, <strong>GAIA</strong> +1.2%, <strong>SGMO</strong> +1%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>SBY</strong> +17.9% (Silver Bay Realty Trust agrees to be acquired for $21.50 per share in cash) </li></ul><p><strong>Select metals/mining stocks trading higher</strong>:</p><ul><li><strong>SBGL</strong> +2.1%, <strong>GOLD</strong> +1.7%, <strong>GFI</strong> +1.7%, <strong>AKS</strong> +1.2%, <strong>AU</strong> +1%, <strong>GDX</strong> +1%, <strong>NEM</strong> +0.9%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>ROX</strong> +45.2% (announces an agreement to supply Goslings Stormy Ginger Beer and Goslings Stormy Diet Ginger Beer to all U.S. Walmart (WMT) stores)</li><li><strong>NSPR</strong> +15.4% (continued strength), <strong>INUV</strong> +13.5% (Inuvo's Vertro and Google entered into a Google Services Agreement)</li><li><strong>LIFE</strong> +10.1% (announces that its product candidate Resolaris was granted Orphan Drug Designation by the FDA for the treatment of limb girdle muscular dystrophy patients)</li><li><strong>DRYS</strong> +8.6% (to initiate a new dividend policy; will pay a regular fixed quarterly dividend of $2.5 million to the holders of common stock)</li><li><strong>CANF</strong> +7.7% (announces new data that 'show its liver disease drug candidate Namodenoson (CF102) prevented liver (hepatic) fibrosis progression in preclinical studies)</li><li><strong>AMD</strong> +1.1% (continued strength)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>DRRX</strong> +2.9% (resumed with a Buy at H.C. Wainwright)</li><li><strong>X</strong> +2.8% (upgraded to Outperform from Market Perform at Cowen)</li><li><strong>CSX</strong> +1.7% (upgraded to Buy from Hold at Deutsche Bank)</li><li><strong>AYR</strong> +1.3% (upgraded to Neutral from Underperform at BofA/Merrill)</li></ul><p><strong>Gapping down<br/> In reaction to disappointing earnings/guidance</strong>:</p><ul><li><strong>FRGI</strong> -14.6%, (also provides strategic update), <strong>ESND</strong> -14.4%</li><li><strong>I</strong> -13.6%, (confirms it will merge w/ OneWeb in a share-for-share transaction; also confirms a definitive share purchase agreement pursuant to which SoftBank (SFTBY) will invest $1.7 bln in newly issued common and preferred shares of the combined co)</li><li><strong>TGT</strong> -13.2%, <strong>CEMP</strong> -11.9%</li><li><strong>PRGO</strong> -11.4%, (also announces the resignation of CFO Judy Brown effective April 1, 2017; Ron Winowiecki appointed CFO effective immediately; to divest Tysabri royalty stream for up to $2.85 billion )</li><li><strong>THC</strong> -11.3%, <strong>KONA</strong> -9.9%, <strong>NVAX</strong> -9.8%, <strong>OPHT</strong> -7.9%, <strong>SPNS</strong> -7.3%, <strong>FTR</strong> -7%, <strong>AAC</strong> -6.5%, <strong>KRA</strong> -5.9%, <strong>WDAY</strong> -5.3%, <strong>ZTO</strong> -4.5%, <strong>EXEL</strong> -4.3%</li><li><strong>IPWR</strong> -4.2%, (enters into a definitive securities purchase agreement with various investors to raise gross proceeds of approx. $15 mln in a private placement of common stock and warrants to purchase common stock)</li><li><strong>CPE</strong> -4.2%, <strong>VRX</strong> -4.2%, <strong>KTOS</strong> -3%, <strong>DS</strong> -2.3%, <strong>ENDP</strong> -2%, <strong>LNG</strong> -1.9%, <strong>GPL</strong> -1.6%, <strong>OKS</strong> -1.5%, <strong>KITE</strong> -1.5%, <strong>APLE</strong> -1.2%, <strong>AZO</strong> -0.9%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>NVAX</strong> -9.8% (pulling back after closing near highs with notable afternoon move to highs)</li><li><strong>OWCP</strong> -9.3% (after closing approx 30% higher on Monday)</li><li><strong>TTNP</strong> -7.9% (receives FDA communication on ropinirole implant Investigational New Drug Application; FDA indicated that it will require final release test data)</li><li><strong>PULM</strong> -7.2% (continued strength)</li><li><strong>HTGM</strong> -7.2% (modestly pulling back following 154% gain yesterday)</li><li><strong>ORA</strong> -4.2% (provides response to reports about potential transaction)</li><li><strong>TCAP</strong> -3.6% (announces the commencement of a public offering of 7,000,000 shares of common stock ), <strong>O</strong> -2.5% (upsizes offering by by 2.05 mln shares and prices 10.85 mln shares shares of common stock at $62.00)</li><li><strong>KR</strong> -1.8% (in sympathy with TGT results)</li><li><strong>TZOO</strong> -1.6% (following PCLN results)</li><li><strong>SQ</strong> -1.3% (commences $350 mln offering of convertible senior notes due in 2022)</li><li><strong>WMT</strong> -1.2% (in sympathy with TGT results)</li><li><strong>JPM</strong> -0.9% (hosts Investor Day, provides Q1 outlook)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>CENX</strong> -3.8% (downgraded to Sell from Hold at Deutsche Bank)</li><li><strong>FSLR</strong> -3.4% (initiated with a Sell at Axiom Capital)</li><li><strong>TRIP</strong> -1.4% (downgraded to Underperform from Hold at Needham)</li></ul></td> </tr></table>"